Stockreport

CTI Biopharma Accelerated Review, And Other News: The Good, Bad, And Ugly Of Biopharma [Seeking Alpha]

CTI BioPharma Corp.  (CTIC) 
Last cti biopharma corp. earnings: 11/1 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: ctibiopharma.com
PDF Summary CTI Biopharma received accelerated review tag for pacritinib. Collegium acquires rights to Nucynta. Inovio amended its equity offering. CTI BioPharma Receives Ac [Read more]